Self-immolative nitrogen mustard prodrugs for suicide gene therapy

Journal of Medicinal Chemistry

Volumn 41, Issue 26, 1998, Pages 5297-5309

  Niculescu Duvaz, Dan ^a   Niculescu Duvaz, Ion ^a   Friedlos, Frank ^a   Martin, Janet ^a   Spooner, Robert ^a   Davies, Lawrence ^a   Marais, Richard ^a   Springer, Caroline J ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORMETHINE DERIVATIVE; GLUTAMIC ACID DERIVATIVE; PRODRUG;

ANIMAL CELL; ARTICLE; CYTOTOXICITY; CYTOTOXICITY TEST; DRUG ACTIVITY; DRUG POTENCY; DRUG RELEASE; DRUG STRUCTURE; DRUG SYNTHESIS; GENE THERAPY; NONHUMAN; SUICIDE GENE;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; COLORECTAL NEOPLASMS; DRUG SCREENING ASSAYS, ANTITUMOR; GAMMA-GLUTAMYL HYDROLASE; GENE THERAPY; INHIBITORY CONCENTRATION 50; MECHLORETHAMINE; MICE; MUTATION; PRODRUGS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032542264     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm980425k     Document Type: Article

References (29)

1. Jarman, M. The development of anticancer drugs. Chem. Br. 1989, 25, 51-54.
2. Zhang, W. W.; Fujiwara, T.; Grimm, E. A.; Roth, J. A. Advances in cancer gene theraphy. Adv. Pharmacol. (San Diego) 1995, 6, 289-341.
3. Bridgewater, G.; Springer, C. J.; Knox, R.; Minton, N.; Michael, P.; Collins, M. Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB1954. Eur. J. Cancer 1995, 31A, 2362-2370.
4. Huber, B. A.; Richards, C. A.; Krenitsky, T. A. Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: An innovative approach for cancer therapy. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 8039-8043.
5. Niculescu-Duvaz, I.; Spooner, R. A.; Marais, R.; Springer, C. J. S. Gene-directed enzyme prodrug therapy. Bioconjugate Chem. 1998, 9, 4-22.
6. Carl, P. L.; Chakravarty, P. K.; Katzenellenbogen, J. A. A novel connector linkage applicable in prodrug design. J. Med. Chem. 1981, 24, 479-480.
7. Wakselman, M. 1,4 and 1,6 eliminations from hydroxy- and amino-substituted benzyl systems: chemical and biochemical applications. N. J. Chim. 1983, 7, 439-447.
8. Schmidt, F.; Florent, J.-C.; Monneret, C.; Straub, R.; Czech, J.; Gerken, M.; Bosslet, K. Glucuronide prodrugs of hydroxy compounds for antibody directed enzyme prodrug therapy (ADEPT): a phenol nitrogen mustard carbamate. Bioorg. Med. Chem. Lett. 1997, 7, 1071-1076.
9. Friedlos, F.; Denny, W. A.; Palmer, B. D.; Springer, C. J. S. Mustard prodrugs for activation by Escherichia coli nitroreductase in gene-directed enzyme prodrug therapy. J. Med. Chem. 1997, 40, 1270-1275.
10. Sherwood, R. F.; Melton, R. G.; Alwan, S. M.; Hughes, P. Purification and properties of carboxypeptidase G2 Pseudonomas sp strain RS-16. Eur. J. Biochem. 1985, 24, 447-453.
11. Springer, C. J.; Antoniw, P.; Bagshawe, K. D.; Searle, F.; Bisset, G. M. F.; Jarman, M. Novel prodrugs which are activated to cytotoxic alkylating agents by carboxypeptidase G2. J. Med. Chem. 1990, 33, 677-681.
12. Springer, C. J.; Niculescu-Duvaz, I.; Pedley, R. B. Novel prodrugs of alkylating agents derived from 2-fluoro- and 3-fluoro benzoic acids for antibody-directed enzyme prodrug therapy. J. Med. Chem. 1994, 37, 2361-2370.
13. Springer, C. J.; Dowell, R. L.; Burke, P. J.; Hadley, E.; Davies, D. H.; Blakey, D. C.; Melton, R. G.; Niculescu-Duvaz, I. Optimization of alkylating prodrugs derived from phenol and aniline mustards: a new clinical candidate prodrug (ZD2767) for ADEPT. J. Med. Chem. 1995, 38, 5051-5065.
14. Dowell, R.; Springer, C. J.; Davies, D. H.; Hadley, E. M.; Burke, P. J.; Boyle, F. T.; Melton, R. G.; Connors, T. A.; Blakey, D. C.; Mauger, A. B. New mustards prodrugs for antibody-directed enzyme prodrug therapy: alternative for the amide link. J. Med. Chem. 1996, 39, 1100-1105.
15. Marais, R.; Spooner, R. A.; Stribbling, S. M.; Light, Y.; Martin, J.; Springer, C. J. S. A cell surface tethered enzyme improves efficiency in gene-directed enzyme prodrug therapy. Nature Biotechnol. 1997, 15, 1373-1377.
16. Ross, W. C. J. Biological alkylating agents; Butterworth: London, 1962.
17. Corey, E. J.; Venkateswarlu, A. Protection of hydroxyl groups as tert-butyltrimethylsilyl derivatives. J. Am. Chem. Soc. 1972, 94, 6190-6191.
18. Hanessian, S.; Lavallee, P. The preparation and the utility of tert-butyldiphenylsilyl ethers. Can. J. Chem. 1975, 53, 2975-2977.
19. Kruse, C. G.; Wijsman, A.; van der Gen, A. Synthetic applications of 2-chloro-1,3-dithiane. 2. Reaction with carbon nucleophiles. J. Org. Chem. 1979, 44, 1847-1851.
20. Alexander, R. P.; Beeley, N. R. A.; O'Driscoll, M.; O'Neil, F. P.; Millican, T. A.; Pratt, A. J.; Willenbrock, F. W. Cephalosporin nitrogen mustard carbamate prodrugs for "ADEPT". Tetrahedron Lett. 1991, 32, 3269-3272.
21. Dubowchik, G. M.; Dalton King, H.; Pham-Kaplita, K. Efficient mitomycin C coupling with stable p-nitro-benzyl carbonates using N-hydroxybenzotriazole as a catalytic additive. Tetrahedron Lett. 1997, 38, 5261-5264.
22. Perrone, E.; Alpegiani, M.; Bedeschi, A.; Zarini, F.; Della Bruna, C.; Franceschi, G. Penem derivatives. EP 0 236 880 A2, 1987.
23. Greene, T. W.; Wuts, P. G. M. Protective groups in organic chemistry; John Wiley & Sons: New York, 1991.
24. Olofson, R. A.; Cuomo, J. A regioselective and stereospecific route to enol carbonates and carbamates: closer look at a "naked anion". Tetrahedron Lett. 1980, 21, 819-822.
25. Hollitzer, O.; Seewald, A.; Steglich, W. 4,6-Diphenylthieno[3,4-d][1,3]dioxol-2-one 5,5-dioxide, a novel activating agent for peptide synthesis. Angew. Chem., Int. Ed. Engl. 1976, 5, 444-445.
26. Schmidt, H.; Hollitzer, O.; Seewald, A.; Steglich, W. Eine einfache Synthese von Harnstoffe, Urethanen und Isocyanaten. Chem. Ber. 1979, 112, 727-733.
27. Palmer, B. D.; Wilson, W. R.; Pullen, S. M.; Denny, W. A. Hypoxia-selective antitumor agents. 3. Relationships between structure and cytotoxicity against cultured tumor cells for substituted N,N-bis(2-chloroethyl)anilines. J. Med. Chem. 1990, 33, 112-121.
28. Minton, N. P.; Atkinson, T.; Sherwood, R. F. Molecular cloning of the Pseudomonas carboxypeptidase G2 gene and its expression in Escherichia coli and Pseudomonas putida. J. Bacteriol. 1983, 156, 1222-1227.
29. Marais, R.; Spooner, R. A.; Light, Y.; Martin, J.; Springer, C. J. Gene-directed enzyme prodrug therapy with a mustard prodrug/ carboxypeptidase G2 combination. Cancer Res. 1996, 56, 4735-4742.